irofulven has been researched along with thiotepa in 2 studies
| Studies (irofulven) | Trials (irofulven) | Recent Studies (post-2010) (irofulven) | Studies (thiotepa) | Trials (thiotepa) | Recent Studies (post-2010) (thiotepa) |
|---|---|---|---|---|---|
| 99 | 22 | 7 | 2,858 | 408 | 284 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Estes, L; Kelner, MJ; McMorris, TC; Rojas, RJ; Trani, NA | 1 |
2 other study(ies) available for irofulven and thiotepa
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Aziridines; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Transplantation; Sesquiterpenes; Thiotepa; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |